Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)
DTG-based regimens demonstrated higher levels of effectiveness and durability compared to DRV- or RAL-based regimens and had similar treatment responses as BIC- and EVG-based regimens among ART-experienced older PWH.
Authors
- Lei Yan (ORCID: https://orcid.org/0000-0002-4779-2688)
- Amy C. Justice (ORCID: https://orcid.org/0000-0003-0139-5502)
- Kirsha S. Gordon (ORCID: https://orcid.org/0000-0002-4925-1914)
- Mihaela Aslan (ORCID: https://orcid.org/0000-0002-5041-010X)
- Cassidy Henegar (ORCID: https://orcid.org/0000-0002-4566-1174)
- Vincent C. Marconi (ORCID: https://orcid.org/0000-0001-8409-4689)
- Vani Vannappagari (ORCID: https://orcid.org/0000-0002-0157-9689)
- Charles B. Hicks
Institutions
- Emory University (US)
- Atlanta Medical Center (US)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Atlanta VA Medical Center (US)
Publication Details
- Journal
- AIDS Research and Therapy
- Published
- 2024-12-21
- DOI
- https://doi.org/10.1186/s12981-024-00681-w
- Citations
- 3
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- U.S. Department of Veterans Affairs
- Eli Lilly and Company
- Gilead Sciences
- Emory University
- ViiV Healthcare
- National Institutes of Health
- Center for AIDS Research, University of Washington
- National Institute on Alcohol Abuse and Alcoholism